Albert Schat, Ph.D.
HomeAbout Dr. SchatzArticles by Dr. SchatzArchived CollectionsSite MapContact Us

Search is Powered by: Google

(Note from Webmaster: Google has indexed very few pages on this web site. The Google Search above may not reflect all content on this site.)

Source: The Passaic Herald-News: October 23, 1952
Print Article | Open Image Viewer

Rutgers Man Wins 1952 Nobel Prize

Waksman Hailed For Discovery Schatz Says He Shares


STOCKHOLM, Sweden (UP) – The 1952 Nobel Prize in physiology and medicine was awarded jointly today to an American and a British scientist.

The winners of the $32,910.51 prize were Dr. Selman A Waksman, director of the Rutgers University Institute of Microbiology, and Dr. Hans Adolf Krebs, professor of biochemistry of Sheffield University, England.

Waksman and Krebs each will get one-half of the prize money. The awards will be distributed by King Gustaf Adolf at the Nobel festival December 10.

To Fight TB

Waksman, 64, discoverer of the "wonder drug" streptomycin, used in combatting tuberculosis, became the 14th American to receive the prize in medicine.

Krebs, 52, became the 10th British citizen to get the prize. He has made important contributions to the knowledge of the complicated combustion processes in the human body.

At the December 10 ceremony they will appear with winners in the fields of literature, chemistry and physics whose names will be announced November 6. There will be no peace prize this year.

Waksman lives in an old, modest home in New Brunswick, N. J., with his wife, Bertha. They have a son, Dr. Byron Halstead, who is a physician in a Boston hospital.

Found in '43

The scientist and his team of researchers discovered streptomycin-the first useful weapon in the fight against tuberculosis-in 1943.

Three years ago he and one of his assistants announced a promising new discovery, neomycin.

In 1949 Waksman turned over his patent rights on streptomycin to the Rutgers Research and Endowment Foundation. Last year he contributed half of his 10 per cent share of the royalties to encourage the study of microbiology throughout the world. Another 10 per cent previously had gone to his former assistants after one of them, Dr. Albert Schatz, brought suit.